- Home
- MURA vs TBHC Comparison
MURA vs TBHC Comparison
Compare MURA & TBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- TBHC
- Stock Information
- Founded
- MURA 2013
- TBHC 1966
- Country
- MURA Ireland
- TBHC United States
- Employees
- MURA N/A
- TBHC N/A
- Industry
- MURA
- TBHC Other Specialty Stores
- Sector
- MURA
- TBHC Consumer Discretionary
- Exchange
- MURA Nasdaq
- TBHC Nasdaq
- Market Cap
- MURA 36.0M
- TBHC 40.4M
- IPO Year
- MURA N/A
- TBHC N/A
- Fundamental
- Price
- MURA $2.09
- TBHC $1.51
- Analyst Decision
- MURA Buy
- TBHC
- Analyst Count
- MURA 2
- TBHC 0
- Target Price
- MURA $6.00
- TBHC N/A
- AVG Volume (30 Days)
- MURA 106.1K
- TBHC 137.5K
- Earning Date
- MURA 11-04-2025
- TBHC 12-05-2025
- Dividend Yield
- MURA N/A
- TBHC N/A
- EPS Growth
- MURA N/A
- TBHC N/A
- EPS
- MURA N/A
- TBHC N/A
- Revenue
- MURA N/A
- TBHC $420,610,000.00
- Revenue This Year
- MURA N/A
- TBHC N/A
- Revenue Next Year
- MURA N/A
- TBHC N/A
- P/E Ratio
- MURA N/A
- TBHC N/A
- Revenue Growth
- MURA N/A
- TBHC N/A
- 52 Week Low
- MURA $0.95
- TBHC $1.20
- 52 Week High
- MURA $4.74
- TBHC $2.40
- Technical
- Relative Strength Index (RSI)
- MURA 52.55
- TBHC 42.95
- Support Level
- MURA $2.06
- TBHC $1.52
- Resistance Level
- MURA $2.10
- TBHC $1.64
- Average True Range (ATR)
- MURA 0.01
- TBHC 0.11
- MACD
- MURA 0.00
- TBHC -0.01
- Stochastic Oscillator
- MURA 66.67
- TBHC 17.14
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About TBHC The Brand House Collective Inc.
The Brand House Collective Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.